Abstract
The clinical diagnosis of Alzheimer’s disease, at its early stage, remains a difficult task. Advanced imaging technologies and laboratory assays to detect Aβ peptides Aβ42 and Aβ40, total and phosphorylated tau in CSF provide a set of biomarkers of developing AD brain pathology and facilitate the diagnostic process. The search for biofluid biomarkers, other than in CSF, and the development of biomarker assays have accelerated significantly and now represent the fastest-growing field in AD research. The goal of this study was to determine the differential enrichment of noncoding RNAs (ncRNAs) in plasma-derived extracellular vesicles (EV) of AD patients and Cognitively Normal controls (NC). Using RNA-seq, we profiled four significant classes of ncRNAs: miRNAs, snoRNAs, tRNAs, and piRNAs. We report a significant enrichment of SNORDs – a group of snoRNAs, in AD samples compared to NC. To verify the differential enrichment of two clusters of SNORDs – SNORD115 and SNORD116, localized on human chromosome 15q11-q13, we used plasma samples of an independent group of AD patients and NC. We applied ddPCR technique and identified SNORD115 and SNORD116 with a high discriminatory power to differentiate AD samples from NC. The results of our study present evidence that AD is associated with changes in the enrichment of SNORDs, transcribed from imprinted genomic loci, in plasma EV and provide a rationale to further explore the validity of those SNORDs as plasma biomarkers of AD.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
National Institutes of Health: AG056371, AG057565, AG066198, ES024233, IL & RK; Alzheimer's Association, grant number 2018-AARG-590509, NFF.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All samples were identified through the University of Pittsburgh Alzheimer's Disease Research Center (ADRC). The samples were collected according to protocols approved by the University of Pittsburgh Institutional Review Board and Committee for Oversight of Research Involving the Dead (CORID, No 731).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The sequencing datasets are assembled in the required format and upon the acceptance of the manuscript for publication will be submitted and will be available from NCBI GEO.
List of Abbreviations
- (AD)
- Alzheimer’s disease
- (Aβ)
- Amyloid beta
- (APOE)
- Apolipoprotein E
- (AUC)
- Area Under the Curve
- (SNORDs)
- Box C/D small nucleolar RNAs
- (SNORAs)
- Box H/ACA small nucleolar RNAs
- (CSF)
- Cerebrospinal fluid
- (CDR)
- Clinical Dementia Rating
- (C)
- Controls
- (ddPCR)
- Droplet digital PCR
- (ESCRT)
- Endosomal sorting complex required for transport
- (exRNAs)
- Extracellular RNAs
- (EV)
- Extracellular vesicles
- FDR
- (False Discovery Rate)
- (HSP70)
- Heat shock protein 70
- (HDL)
- High density lipoprotein
- (miRNAs)
- Micro RNAs
- (MMSE)
- Mini Mental Score Examination
- (NTA)
- Nanoparticle Tracking Analysis
- (ncRNAs)
- Noncoding RNAs
- (PMBC)
- Peripheral Mononuclear Blood Cells
- (PWS)
- Prader-Willi syndrome
- (piRNAs)
- Piwi-interacting RNAs
- (ROC)
- Receiver Operating Characteristic
- (5-HT2C)
- Serotonin receptor subtype 5
- (snoRNAs)
- Small nucleolar RNAs
- (tRNAs)
- Transfer RNAs
- (TSG101)
- Tumor susceptibility gene 101